ストックスクリーナーアプリを入手
11.48
16.27%
-2.23
アフターアワーズ：
12.00
0.52
+4.53%
前日終値:
$13.71
開ける：
$9.48
24時間の取引高:
2.18M
Relative Volume:
3.71
時価総額：
$722.35M
収益：
$512.35M
当期純損益:
$-156.23M
株価収益率:
-2.5066
EPS:
-4.58
ネットキャッシュフロー:
$7.98M
1週間 パフォーマンス:
-13.75%
1か月 パフォーマンス:
-2.30%
6か月 パフォーマンス:
+189.17%
1年 パフォーマンス:
+198.96%
1日の値動き範囲:
$7.30
$11.80
1週間の範囲:
$7.30
$14.38
52週間の値動き範囲:
$3.36
$14.38
Bioventus Inc Stock (BVS) Company Profile
名前
Bioventus Inc
セクター
電話
(919) 474-6700
住所
4721 EMPEROR BOULEVARD, SUITE 100, DURHAM
Bioventus Inc Stock (BVS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2023-08-09 | アップグレード | Craig Hallum | Hold → Buy |
| 2022-11-22 | ダウングレード | Craig Hallum | Buy → Hold |
| 2022-11-09 | ダウングレード | Canaccord Genuity | Buy → Hold |
| 2022-11-09 | ダウングレード | JP Morgan | Overweight → Underweight |
| 2022-03-15 | 開始されました | Craig Hallum | Buy |
| 2021-11-15 | 再開されました | Morgan Stanley | Overweight |
| 2021-11-10 | 再開されました | JP Morgan | Overweight |
| 2021-07-01 | ダウングレード | Goldman | Buy → Neutral |
| 2021-03-08 | 開始されました | Canaccord Genuity | Buy |
| 2021-03-08 | 開始されました | Goldman | Buy |
| 2021-03-08 | 開始されました | JP Morgan | Overweight |
| 2021-03-08 | 開始されました | Morgan Stanley | Overweight |
すべてを表示
Bioventus Inc (BVS) 最新ニュース
Bioventus (NYSE:BVS) Shares Gap DownHere's What Happened - MarketBeat
How Are Things Looking For Bioventus Inc (NASDAQ: BVS) For The Short Term? - Stocks Register
BVSBioventus Inc. Latest Stock News & Market Updates - StockTitan
Bioventus: Q3 Earnings Snapshot - San Francisco Chronicle
Bioventus Inc Reports Q3 2024 Earnings: Revenue Hits $139 Millio - GuruFocus.com
Bioventus (NYSE:BVS) Updates FY 2024 Earnings Guidance - MarketBeat
Bioventus Reports Third Quarter Financial Results - The Manila Times
Bioventus reports Q3 adjusted EPS 6c, consensus 3c - TipRanks
Are Medical Stocks Lagging Bioventus (BVS) This Year? - Yahoo Finance
Bioventus Inc (BVS) Q3 2024 Earnings Report Preview: What To Loo - GuruFocus.com
Bioventus Inc (BVS) Q3 2024 Earnings Report Preview: What To Look For - Yahoo Finance
Bioventus stock soars to 52-week high, hits $13.65 - Investing.com India
Bioventus stock soars to 52-week high, hits $13.65 By Investing.com - Investing.com South Africa
Bioventus (BVS) Scheduled to Post Quarterly Earnings on Tuesday - MarketBeat
Should Bioventus Stock Be in Your Portfolio Pre-Q3 Earnings? - MSN
Bioventus to Report Third Quarter of Fiscal Year 2024 Financial Results on November 5, 2024 - The Manila Times
Long Term Trading Analysis for (BVS) - Stock Traders Daily
Bioventus (NYSE:BVS) Reaches New 1-Year HighStill a Buy? - MarketBeat
Bioventus stock soars to 52-week high, hits $13.14 - Investing.com India
SG Americas Securities LLC Lowers Stock Position in Bioventus Inc. (NYSE:BVS) - Defense World
Bioventus Surges 73% in Three Months: Time to Buy the Stock? - Yahoo Finance
Are Medical Stocks Lagging ChromaDex (CDXC) This Year? - Yahoo Finance
Bioventus stock soars to 52-week high of $12.43 amid growth By Investing.com - Investing.com South Africa
Bioventus (NYSE:BVS) Reaches New 52-Week HighStill a Buy? - MarketBeat
Bioventus stock soars to 52-week high of $12.43 amid growth - Investing.com Australia
Dimensional Fund Advisors LP Buys 58,954 Shares of Bioventus Inc. (NYSE:BVS) - MarketBeat
Bone Growth Products Global Market Report |Bioventus, Djo, Johnson & Johnson, Medtronic, Orthofix, Stryker, Zimmer Biome – IndiaPolitics.com - IndiaPolitics.com
Bioventus (NYSE:BVS) Trading Up 7.5%Here's What Happened - MarketBeat
Bioventus (NYSE:BVS) Shares Up 7.5%What's Next? - MarketBeat
Buying Buzz: Bioventus Inc [BVS] Director Bartholdson John A. acquires 80,000 shares of the company - Knox Daily
Ratio Revelations: Bioventus Inc (BVS)’s Financial Metrics in the Spotlight - The Dwinnex
Bioventus Inc (BVS) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance
Bioventus Inc (BVS) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada
Bank of Montreal Can Invests $774,000 in Bioventus Inc. (NYSE:BVS) - MarketBeat
Marshall Wace LLP Has $1.91 Million Position in Bioventus Inc. (NYSE:BVS) - MarketBeat
U.S. Osteoarthritis Injectables Market Analysis 2024-2030: Rising Prevalence of Osteoarthritis & Increase in R&D Activities for Injectable Drug Developments Spurs Growth - GlobeNewswire Inc.
Bioventus maintains Buy rating by Canaccord Genuity - Investing.com Canada
Bioventus Announces Divestiture Of Its Advanced Rehabilitation Business To Accelmed Partners - citybiz
Bioventus Announces Divestiture of its Advanced Rehabilitation Business to Accelmed Partners - The Manila Times
Bioventus Inc. (NYSE:BVS) Holdings Reduced by Nantahala Capital Management LLC - MarketBeat
Bioventus Inc (BVS) receives a Buy rating from Canaccord Genuity - Knox Daily
Bioventus Inc. (NYSE:BVS) Shares Bought by Rhumbline Advisers - MarketBeat
Bioventus stock soars to 52-week high, hits $12.15 - Investing.com
Bioventus (NYSE:BVS) Hits New 1-Year High After Analyst Upgrade - MarketBeat
Bioventus stock soars to 52-week high, hits $12.15 By Investing.com - Investing.com UK
Bioventus (NYSE:BVS) Price Target Increased to $17.00 by Analysts at Craig Hallum - MarketBeat
(BVS) Technical Data - Stock Traders Daily
Zacks.com featured highlights include Bioventus, Great Lakes Dredge & Dock and AxoGen - Yahoo Finance
Bank of New York Mellon Corp Invests $647,000 in Bioventus Inc. (NYSE:BVS) - MarketBeat
The Attractiveness of Investing In Bioventus Inc (BVS) is Growing - Knox Daily
First September Gains in 5 Years? Buy 3 Breakout Stocks Now - Yahoo Finance
Bioventus Inc (BVS) 財務データ
収益
当期純利益
現金流量
EPS
0.47%
1.00%
大文字化:
|
ボリューム (24 時間):